查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1673847

富血小板血浆市场按类型、来源、应用和地区划分

Platelet Rich Plasma Market, By Type, By Origin, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球富血小板血浆市场规模估计为 6.205 亿美元，预计到 2032 年将达到 14.337 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 12.7%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 6.205亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025 年至 2032 年复合年增长率 12.70％ 2032 年金额预测 14.337亿美元
数字。 2025 年富血小板血浆市场占有率（%）（按地区划分）
富含血小板血浆市场-IMG1

富血小板血浆（PRP）是从少量全血中提取的血小板浓缩物。富含血小板的血浆含有多种已知可促进组织再生的生长因子。富含血小板血浆疗法是一种即将问世的治疗方法多种肌肉骨骼疾病的方法，包括肌腱炎、关节损伤和关节炎。血小板分泌的生长因子会透过吸引干细胞、刺激细胞增生和分化来诱导组织癒合。随着运动伤害和退化性疾病的日益流行，富血小板血浆已成为外科手术和组织修復药物的有希望的替代品。

市场动态

最近的趋势表明，富含血小板血浆由于其再生特性正在被各个治疗领域迅速采用。运动医学的发展和肌肉骨骼疾病病例的增加是该市场的主要驱动力。然而，富含血小板血浆程序和设备的高成本可能会阻碍更广泛的采用。廉价的富血小板血浆製备套件的开发提供了巨大的机会。市场领导正在投资研发以扩大核准的临床适应症。例如，监管部门核准使用富含血小板的血浆进行脸部回春开闢了新的途径。

研究的主要特点

  • 本报告对全球富血小板血浆市场进行了详细分析，并提供了预测期（2025-2032）的市场规模（百万美元）和年复合成长率（CAGR%），假设 2024 年为基准年。
  • 它还强调了各个领域的潜在收益成长机会，并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
  • 全球富血小板血浆市场的主要企业根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行分析。
  • 主要企业包括 Arthrex, Inc.、Ester Medical、Zimmer Biomet、Terumo Corporation、Glofinn Oy、Medira Ltd.、Regen Lab SA、CollPlant、Generex BIoTechnology Corporation、Estar Technologies Ltd.、Cesca Therapeutics, Inc.、Arteriocyte Medical、Harvestal Corporation.
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球富血小板血浆市场迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过全球富含血小板血浆市场分析中使用的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 製造商收益
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

4. 全球富含血小板血浆市场 - COVID-19 疫情的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球富含血小板血浆市场（按类型）

  • 介绍
  • 纯富含血小板血浆
  • 高白血球富血小板血浆
  • 纯富血小板纤维蛋白
  • 富含白血球富含血小板的纤维蛋白

6. 全球富含血小板血浆市场，依来源划分，2020 年至 2032 年

  • 介绍
  • 自体移植
  • 同种异体
  • 同源基因

7. 全球富含血小板血浆市场（按应用划分），2020 年至 2032 年

  • 介绍
  • 神经外科
  • 整容手术
  • 整形外科
  • 一般外科
  • 其他的

8. 2020 年至 2032 年全球富血小板血浆市场（依地区划分）

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 公司简介
    • Arthrex, Inc.
    • Ester Medical
    • Zimmer Biomet
    • Terumo Corporation
    • Glofinn Oy
    • Medira Ltd.
    • Regen Lab SA
    • CollPlant
    • Generex BIoTechnology Corporation
    • Estar Technologies Ltd.
    • Cesca Therapeutics, Inc.
    • Arteriocyte Medical Systems
    • Harvest Technologies Corp.
    • EmCyte Corporation
    • T-BIoTechnology Ltd.
    • Isto Biologics

第 10 章 分析师观点

  • 兴衰
  • 一致的机会地图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI936

Global Platelet Rich Plasma Market is estimated to be valued at USD 620.5 Mn in 2025 and is expected to reach USD 1,433.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 620.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.70% 2032 Value Projection: USD 1,433.7 Mn
Figure. Platelet Rich Plasma Market Share (%), By Region 2025
Platelet Rich Plasma Market - IMG1

Platelet Rich Plasma (PRP) is an enriched concentration of platelets extracted from a small volume of whole blood. It contains several growth factors that are known to accelerate tissue regeneration. PRP therapy is an upcoming treatment for various musculoskeletal conditions such as tendonitis, joint injuries, and arthritis. The secretion of growth factors from platelets induces tissue healing by attracting stem cells and stimulating cell proliferation and differentiation. With the increasing prevalence of sports injuries and degenerative conditions, PRP is emerging as a promising alternative to surgical interventions and medications for tissue repair.

Market Dynamics:

Recent trends indicate the rapid adoption of PRP in various therapeutic areas due to its regenerative properties. Growth in sports medicine and rising cases of musculoskeletal disorders are major drivers for this market. However, high costs associated with PRP procedures and equipment may restrain wider adoption. The development of inexpensive PRP preparation kits presents significant opportunities. Market leaders are investing in R&D to expand approved clinical indications. For example, regulatory approvals for use of PRP in facial rejuvenation opens new avenues.

Key Features of the Study:

  • This report provides an in-depth analysis of the global platelet rich plasma market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global platelet rich plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this Arthrex, Inc., Ester Medical, Zimmer Biomet, Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp., EmCyte Corporation, T-Biotechnology Ltd., and Isto Biologics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global platelet rich plasma market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet rich plasma market.

Detailed Segmentation-

  • By Type:
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • By Origin:
    • Autologous
    • Allogenic
    • Homologues
  • By Application:
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa

Company Profiles:

  • Arthrex, Inc.
  • Ester Medical
  • Zimmer Biomet
  • Terumo Corporation
  • Glofinn Oy
  • Medira Ltd.
  • Regen Lab S.A.
  • CollPlant
  • Generex Biotechnology Corporation
  • Estar Technologies Ltd.
  • Cesca Therapeutics, Inc.
  • Arteriocyte Medical Systems
  • Harvest Technologies Corp.
  • EmCyte Corporation
  • T-Biotechnology Ltd.
  • Isto Biologics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Origin
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Platelet Rich Plasma Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Platelet Rich Plasma Market, By Type, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pure PRP
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Leukocyte rich PRP
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pure PRF
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Leukocyte rich PRF
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Platelet Rich Plasma Market, By Origin, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Autologous
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Allogenic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Homologues
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Platelet Rich Plasma Market, By Application, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Neurosurgery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Cosmetic Surgery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Orthopedic Surgery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • General Surgery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Platelet Rich Plasma Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Company Profiles
    • Arthrex, Inc.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Ester Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Zimmer Biomet
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Glofinn Oy
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Medira Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Regen Lab S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • CollPlant
    • Generex Biotechnology Corporation
    • Estar Technologies Ltd.
    • Cesca Therapeutics, Inc.
    • Arteriocyte Medical Systems
    • Harvest Technologies Corp.
    • EmCyte Corporation
    • T-Biotechnology Ltd.
    • Isto Biologics

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact

"